Rationale: Microparticles are cell-derived membrane vesicles, relevant to a range of biological responses and known to be elevated in cardiovascular disease.
C ell-derived microparticles are subcellular membrane vesicles, ranging in size from 0.1 to 1.0 μm, that bud off during cell activation or apoptosis. 1 They are identifiable in the circulation by their parent cell surface markers. 2 Certain subtypes, particularly platelet derived, increase after strenuous exercise in healthy individuals, 3, 4 which suggests that microparticles may have a physiological function to remove stress-induced cellular by-products. 5, 6 Such a response could be relevant to cardiovascular disease pathogenesis because failure to clear microparticles could lead to an increase in the circulating levels of proatherogenic factors. [7] [8] [9] In addition, ineffective microparticle release could lead to localized cell damage. 10, 11 We studied whether there is a stress-induced dynamic release and clearance of microparticles in patients exposed to cardiac stress during dobutamine echocardiography. 12 The group included those with atypical symptoms in whom coronary disease is excluded, as well as those with complex disease who require risk stratification, which allowed study of variation in response between those with and without vascular disease.
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Methods
Expanded Methods can be found in the Online Data Supplement.
Sample Collection and Analysis
Participants were recruited sequentially from patients undergoing dobutamine stress echocardiography (DSE) at the John Radcliffe Hospital, Oxford. Citrate blood samples were taken peripherally before, immediately after, and 1 hour after DSE. 13 Circulating microparticles were measured by flow cytometry. 14 Functional effect was assessed by procoagulant assay.
Cardiovascular Disease Assessment
DSE identified patients with coronary disease sufficient to cause acute myocardial ischemia to study microparticle response related to ischemia. Medical history and coronary angiography identified patients with vascular disease to determine whether differences in microparticle response relate to vascular disease or ischemia. January 3, 2014
Statistical Analysis
Statistical analysis is detailed in the online-only Data Supplement.
Results

Microparticles and Cardiac Stress
One hundred nineteen participants took part, and 107 had measurements 1 hour after DSE. Immediately after DSE, procoagulant, platelet, erythrocyte, and CD31+CD41− endothelial cell-derived microparticle (EMP) levels rose significantly. One hour later, procoagulant and platelet microparticle levels had returned to baseline. Erythrocyte-derived microparticles had also started to decrease, and CD31+CD41− EMPs had fallen below baseline ( Figure 1 ). Other microparticles did not change during stress (data not shown). The rise in microparticles was correlated with an increase in procoagulant activity, consistent with a clinically relevant functional effect ( Figure 2C ).
Microparticles and Myocardial Ischemia
There were 94 negative and 25 positive DSEs. Participants with a positive DSE were significantly older and had slightly lower cholesterol, but other clinical and echocardiographic variables were similar (Online Table I ). Baseline microparticle levels did not differ between groups (Online Table II ). However, procoagulant, platelet, erythrocyte, and CD31+CD41− EMPs increased in participants after a negative DSE (Figure 2A) , with no change up to 1 hour in those with a positive DSE. Adjustment for risk factors and medication by regression analysis did not alter this finding.
Microparticles and Vascular Disease
To investigate whether this lack of response related to myocardial ischemia or underlying vascular disease, we compared microparticle release in 72 participants with a negative DSE without evidence of vascular disease with microparticle release in 11 participants with known vascular disease. Procoagulant, platelet, and erythrocyte-derived microparticles had not increased in participants with vascular disease ( Figure  2B ). In 14 participants who subsequently underwent coronary angiography, procoagulant, platelet, and erythrocyte-derived microparticles had increased only in individuals with normal coronary arteries ( Figure 3A ). Interestingly, a stress-induced increase in procoagulant and erythrocyte-derived microparticles had occurred in a patient with a positive DSE subsequently found to have normal coronaries, and no change in microparticles had occurred in a patient with a negative DSE found to have coronary disease ( Figure 3B ).
Discussion
We demonstrate a dynamic rapid rise and fall in a broad range of circulating microparticles in response to cardiac stress. Interestingly, this response was not apparent in those who developed myocardial ischemia, which seemed to relate to their underlying vascular disease because no increase was seen in those with a negative stress echo but known vascular disease. Subsequent analysis based on angiographic disease supported these findings.
Our findings are consistent with previous reports of a trend for platelet-derived microparticles to increase after DSE, 15 as well as significant rises in healthy individuals after exercise 3, 4 and a high-fat meal. 16 Our analysis shows that procoagulant, erythrocyte, and platelet-derived microparticle levels are related, and all elevate immediately after DSE. Microparticle levels depend on speed of clearance mechanism, currently thought to involve direct receptor binding of liver or spleen phagocytes to phosphatidylserine or opsonization proteins on the microparticles. 17, 18 Platelet-derived microparticle levels are known to fall rapidly after injection into rabbits 19 and within 30 minutes after infusion in mice, 17 but few studies have investigated human clearance. 20 We found that, within 1 hour, elevated circulating procoagulant, platelet, and EMPs are significantly reduced. Clearance rate differed by cellular origin so that erythrocyte-derived microparticles had not declined as much and CD31+CD41− EMPs fell below baseline. Because EMPs carry von Willebrand factor, 21 they present a potential thrombotic risk, which might explain their apparently more rapid clearance mechanism. However, EMP response to cardiac stress, in general, differed. CD31+CD41− EMPs, indicative of endothelial apoptosis, 22 increased, but with a relatively small proportional change. There was no change in CD62E+ EMPs, a marker of endothelial cell activation, 22 or CD144+ EMPs, an independent predictor of future cardiovascular events. 23 Lower concentrations of CD31+CD41− EMPs or the standard negative staining approach, 24, 25 which excludes platelet-derived microparticles but may lead to inclusion of leukocyte-derived microparticles, could explain this. Alternatively, CD31+CD41− EMP release in response to stress may have distinct characteristics because different EMP subpopulations are known to be released in response to different triggers. 22 Although we found no difference in EMP levels between those with and without vascular disease, EMP levels are an independent predictor of cardiovascular events in coronary patients 26 and in those with end-stage renal failure, 27 so EMP stress response in vascular patients may vary from other cellular microparticles. This significant variability in the degree of change in microparticle levels between individuals after cardiac stress raises the interesting possibility that this could be a predictive biomarker. 28 One patient with a normal DSE subsequently had an out-of-hospital arrest and had no microparticle rise during stress. However, lack of microparticle release was an indicator of vascular disease rather than ischemia. A larger study with more extensive angiographic and clinical follow-up will be required to determine prognostic significance of this dynamic response and allows for calculation of positive and negative predictive values. Investigation of dynamic microparticle release from other cells, in particular cardiomyocytes, may be of interest as markers of ischemic burden.
In summary, we demonstrate, in a large cohort, that procoagulant, platelet, erythrocyte, and endothelial-derived microparticles are released and cleared rapidly in response to cardiac stress. This dynamic response was not evident in the group of subjects with vascular disease. Although provisional pending replication, these observations raise the possibility that microparticle release is a protective mechanism to remove cellular stress signals, which is diminished in those with vascular disease. Interventions to enhance release and clearance of microparticles may be relevant for disease prevention. What Is Known?
Sources of Funding
• Microparticles are small membrane vesicles, which can be stimulated to bud off from cells into the circulation and can trigger a range of biological responses. • The cellular origin and quantity of circulating microparticles can be measured. • Certain subtypes have been shown to be elevated in those with cardiovascular disease but also in healthy individuals after exercise.
What New Information Does This Article Contribute?
• Cardiac stress induces a rapid dynamic increase in a broad range of circulating microparticles. • These microparticles are then cleared from the circulation during the next hour. • The stress-induced rise seems to be a normal physiological response that is diminished in those with vascular disease.
Microparticles are subcellular membrane vesicles that bud off from cells into the circulation in response to different stimuli and can be identified, and quantified, based on markers on their surface. Although circulating levels of certain microparticles are increased in people with cardiovascular disease, exercise has also been found to increase levels in healthy subjects. This study investigated whether microparticle release is a normal phenomenon in response to cardiac stress, what type of microparticles are released, how quickly they then clear from the circulation, and whether vascular disease is associated with a different response. A dynamic rapid rise in a broad range of circulating microparticles was demonstrated in patients undergoing a standardized cardiac stress protocol. These microparticles then cleared from the circulation within an hour. Interestingly, this dynamic rise and fall was not apparent in those who had vascular disease, diagnosed based on their medical history and, when available, evidence from coronary angiography. These observations raise the possibility that stress-induced microparticle release may be a biomarker of a physiological response to remove cellular stress signals, which is diminished in those with vascular disease. Interventions to enhance both release and clearance of microparticles may be relevant for disease prevention.
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